IPAX-2 study of TLX101-Tx (¹³¹I-iodofalan) has completed patient enrolment.Maximum dose reached with no dose-limiting toxicities ...

Your pathology report includes vital information about your brain tumor that can guide treatment. Get to know how to ...

A Phase 1 trial shows a personalized DNA vaccine (GNOS-PV01) is safe and doubles survival rates for aggressive glioblastoma.

A personalized DNA vaccine for glioblastoma, an aggressive and incurable brain cancer, appears safe and shows early signs of ...

Glioblastoma vaccine shows promise by activating immune response and improving survival in a phase 1 trial at Siteman Cancer Center.

Discover how a personalized DNA vaccine trained patients’ immune systems to target their own tumors, with one participant ...

Multidimensional analyses demonstrate that repeated DeltEx DRI dosing preserves immune function, drives tumor ...

A potential breakthrough in the fight against glioblastoma, the deadliest form of brain cancer, is emerging from UVA Cancer Center. University of Virginia scientists, with support from the National ...

Researchers headed by teams at Mass General Brigham Cancer Institute and Harvard Medical School have acquired serial biopsies from two recurrent glioblastoma (rGBM) patients who were involved in an ...

A next-generation CAR T cell immunotherapy targeting the urokinase receptor has eliminated treatment-resistant glioblastoma tumours in preclinical models.

Scientists are creating a glioblastoma 'tumor on a chip'—a tiny living system capable of mimicking the key features of the ...

Michael Bolton’s battle with glioblastoma has brought renewed attention to one of the most complex, deadly and treatment-resistant cancers. The singer, 72, told People he was diagnosed in December ...